Ameridose plans voluntary shutdown amid meningitis outbreak

BOSTON, Oct 10 (Reuters) - Pharmacy compounder AmeridoseLLC, which shares common ownership with the company at thecenter of the deadly U.S. meningitis outbreak, plans to shutdown voluntarily for a week as a precautionary move, accordingto a person familiar with the situation.

Ameridose, based in Westborough, Massachusetts, is expectedto announce the shutdown as early as Wednesday, according to aperson familiar with the situation. The source said the move wasstrictly precautionary and that no contamination had been found.

Ameridose is working to distance itself from New EnglandCompounding Center, which distributed thousands of vials of acontaminated steroid that has been implicated in 12 deaths.

Both companies are owned by Gregory Conigliaro, an engineerwho invented a way to turn plastic into pot-hole filler, and hisbrother-in-law, Barry Cadden, a pharmacist in charge of pharmacyoperations at the New England Compounding Center, according torecords filed with Massachusetts authorities.

(Reporting By Tim McLaughlin; Editing by Sandra Maler)

((tim.mclaughlin@thomsonreuters.com)(+1 617-856-4409))